These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 519192)

  • 21. Bromocriptine-induced pregnancies in women with large prolactinomas.
    Bergh T; Nillius SJ; Enoksson P; Larsson SG; Wide L
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):625-31. PubMed ID: 7165972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of treatment with bromocriptine in patients with hyperprolactinaemia.
    al-Suleiman SA; Najashi S; Rahman J; Rahman MS
    Aust N Z J Obstet Gynaecol; 1989 May; 29(2):176-9. PubMed ID: 2803131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancies in women with hyperprolactinaemia: obstetric and endocrinological management of 50 pregnancies in 37 women.
    Randall S; Laing I; Chapman AJ; Shalet SM; Beardwell CG; Kelly WF; Davies D
    Br J Obstet Gynaecol; 1982 Jan; 89(1):20-3. PubMed ID: 7059541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
    Weil C
    Curr Med Res Opin; 1986; 10(3):172-95. PubMed ID: 3525009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy in patients presenting with hyperprolactinaemia.
    Kelly WF; Joplin GF; Doyle FH; Mashiter K; Banks LM; Gordon H
    Br Med J; 1979 Nov; 2(6199):1222-3. PubMed ID: 519378
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute pituitary failure as the presentation of a prolactin cell adenoma during a pregnancy made possible by bromocriptine (author's transl)].
    Linquette M; Buvat J; Gauthier A; Gasnault JP; Pagniez I; Decoulx M; Laine E
    Nouv Presse Med; 1977 Nov; 6(38):3525-L, 3531. PubMed ID: 600724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin studies in "functionless" pituitary tumours.
    Child DF; Nader S; Mashiter K; Kjeld M; Banks L; Fraser TR
    Br Med J; 1975 Mar; 1(5958):604-6. PubMed ID: 1092408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hyperprolactinaemic amenorrhoea.
    Franks S; Jacobs HS; Hull MG; Steele SJ; Nabarro JD
    Br J Obstet Gynaecol; 1977 Apr; 84(4):241-53. PubMed ID: 870009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
    Johnston DG; Hall K; Kendall-Taylor P; Patrick D; Watson M; Cook DB
    Lancet; 1984 Jul; 2(8396):187-92. PubMed ID: 6146751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual abnormalities in a pregnancy following bromocriptin medication.
    Corbey RS; Cruysberg JR; Rolland R
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):69s-71s. PubMed ID: 577605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine].
    Buvat J; Buvat-Herbaut M
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):509-21. PubMed ID: 6754799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
    Jin ZM; Shi YF; Chen GL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of pregnancy on patients with hyperprolactinemia.
    Samaan NA; Leavens ME; Sacca R; Smith K; Schultz PN
    Am J Obstet Gynecol; 1984 Feb; 148(4):466-73. PubMed ID: 6696005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth of a prolactinoma during pregnancy. Case report and review.
    Dommerholt HB; Assies J; Van der Werf AJ
    Br J Obstet Gynaecol; 1981 Jan; 88(1):62-70. PubMed ID: 7459293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy.
    Rasmussen C
    Ups J Med Sci; 1990; 95(1):1-29. PubMed ID: 1977229
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal.
    Woodhouse NJ; Niles N; McDonald D; McCorkell S
    Horm Res; 1985; 21(1):1-9. PubMed ID: 3972334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.